<DOC>
	<DOCNO>NCT00825318</DOCNO>
	<brief_summary>In study , researcher want find patient ultrafiltration ( removal excess fluid ) 6 time week twice-weekly dialysis ( removal excess fluid waste product ) term blood pressure weight . The researcher believe maintain patient estimate target weight throughout week use daily ultrafiltration reduce blood pressure level show similar study . Such reduction blood pressure may reduce incidence cerebral vascular disease , peripheral vascular disease , coronary artery disease , congestive heart failure . The researcher also believe patient ' quality life improve undergoing daily ultrafiltration . Studies show frequent dialysis treatment result few symptom patient . The patient feel well avoid weight gain symptoms patient three time week dialysis . In addition , blood lab result well control , require less medication .</brief_summary>
	<brief_title>Comparison Study Daily Ultrafiltration Twice-weekly Hemodialysis</brief_title>
	<detailed_description />
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Kidney Failure , Chronic</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<criteria>Age great equal 18 year less equal 80 year Stable three treatment per week dialysis schedule least three month prior begin study Residual renal clearance &lt; 1.5ml/min per 35L urea volume Predialysis serum sodium level great 136 mEq/L Noncompliance hemodialysis treatmentsdefined miss 1 treatment 3 month period prior study Unable verbally communicate English Spanish Current requirement hemodialysis three time per week due medical comorbidity ( include fourth session ultrafiltration ) Currently daily nocturnal hemodialysis , less 3 month since discontinue treatment Expected geographic unavailability dialysis center phase trial Less 3 month since patient return acute rejection result allograft failure Currently acute care chronic care hospital Pregnancy Current involvement nonobservational trial Unable unwilling follow study protocol reason ( include mental incompetence ) Unable unwilling provide inform consent sign IRBapproved consent form Pace maker , implantable pump , artificial joint Amputation limb</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>April 2014</verification_date>
	<keyword>End-stage renal disease</keyword>
	<keyword>Chronic kidney disease</keyword>
	<keyword>Hemodialysis</keyword>
</DOC>